AHP2019 recognises Methamphetamine, a central nervous system stimulant that triggers the release of dopamine and norepinephrine in the brain. It has significant enhancing effects on the mood and energy. Medically, methamphetamine is used to treat attention deficit hyperactivity disorder, obesity and narcolepsy. Side-effects may include anorexia, restlessness, arrhythmias, heart attack or stroke.
Methamphetamine is addictive and tolerance develops quickly. Users might also use sedatives to ease anxiety and trouble sleeping. Addiction is difficult to treat, with withdrawal symptoms such as anxiety, excessive sleeping, eating and depression. Relapse rates are high.
Application
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visitwww.abdserotec.com/protocols.
Application Name
Yes
No
Not Determined
Suggested Dilution
ELISA
9ug/ml -
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Storage
Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
